Cargando…

Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care

AIM: Type 2 diabetes is associated with an increased risk of fractures. There are a few studies on the effects of diabetes treatment on fracture risk. The aim was to investigate the fracture risk related to various types of insulin therapy in primary care practices. METHODS: Data from 105,960 type 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pscherer, S, Kostev, K, Dippel, FW, Rathmann, W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767062/ https://www.ncbi.nlm.nih.gov/pubmed/26929655 http://dx.doi.org/10.2147/DMSO.S101370

Ejemplares similares

Risk of hypoglycaemia in type 2 diabetes patients under different insulin regimens: a primary care database analysis
por: Kostev, Karel, et al.
Publicado: (2015)

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
por: Kostev, Karel, et al.
Publicado: (2015)

Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database
por: Rathmann, Wolfgang, et al.
Publicado: (2022)

Correction to: Association of glucose‑lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database
por: Rathmann, Wolfgang, et al.
Publicado: (2022)

Changes in Glycemic Control and Body Weight After Initiation of Dapagliflozin or Basal Insulin Supported Oral Therapy in Type 2 Diabetes: A Primary Care Database Study
por: Kostev, Karel, et al.
Publicado: (2017)

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
por: Pscherer, Stefan, et al.
Publicado: (2010)

Routine care for people with newly diagnosed type 2 diabetes before and during the SARS-CoV-2 pandemic – results from the German Disease Analyzer database
por: Kowall, Bernd, et al.
Publicado: (2023)

Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis
por: Gamble, JM, et al.
Publicado: (2008)

Complexity of antidiabetic medication regimen is associated with increased diabetes-related distress in persons with type 2 diabetes mellitus
por: Luzuriaga, Maria, et al.
Publicado: (2021)

Diabetes incidence before and after COVID-19 vaccination – Results from the German Disease Analyzer database
por: Kowall, Bernd, et al.
Publicado: (2023)

Incidence of newly diagnosed diabetes after Covid-19
por: Rathmann, Wolfgang, et al.
Publicado: (2022)

Association between type 2 diabetes and chronic low back pain in general practices in Germany
por: Jacob, Louis, et al.
Publicado: (2021)

Type 1 diabetes incidence in children and adolescents during the COVID-19 pandemic in Germany
por: van den Boom, Louisa, et al.
Publicado: (2022)

Effects of the COVID‐19 pandemic on clinically diagnosed psychiatric disorders in persons with type 2 diabetes
por: Kowall, Bernd, et al.
Publicado: (2022)

HbA1c target achievement in the elderly: results of the Titration and Optimization trial for initiation of insulin glargine 100 U/mL in patients with type 2 diabetes poorly controlled on oral antidiabetic drugs
por: Fritsche, Andreas, et al.
Publicado: (2019)

Phyto diab care: Phytoremedial database for antidiabetics
por: Luhach, Shruti, et al.
Publicado: (2013)

Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis
por: Mearns, Elizabeth S., et al.
Publicado: (2015)

Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens
por: Sambamoorthi, Usha, et al.
Publicado: (2016)

Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea
por: Choi, Sung Hee, et al.
Publicado: (2017)

Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens
por: Vittorino Gaddi, A, et al.
Publicado: (2014)

Avoiding Time-Related Biases: A Feasibility Study on Antidiabetic Drugs and Pancreatic Cancer Applying the Parametric g-Formula to a Large German Healthcare Database
por: Börnhorst, Claudia, et al.
Publicado: (2021)

Insulin clearance and incretin hormones following oral and “isoglycemic” intravenous glucose in type 2 diabetes patients under different antidiabetic treatments
por: Tura, Andrea, et al.
Publicado: (2022)

Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
por: Bonafede, Machaon M, et al.
Publicado: (2011)

Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study
por: Scheerer, Markus F, et al.
Publicado: (2016)

Antidiabetic Action of Bezafibrate in a Large Observational Database
por: Flory, James H., et al.
Publicado: (2009)

DIACAN: Integrated Database for Antidiabetic and Anticancer Medicinal Plants
por: James, Priyanka, et al.
Publicado: (2013)

Retrospective nationwide study on the trends in first‐line antidiabetic medication for patients with type 2 diabetes in Japan
por: Bouchi, Ryotaro, et al.
Publicado: (2021)

Cardiovascular disease prevalence in type 2 diabetes – an analysis of a large German statutory health insurance database
por: Gabler, Maximilian, et al.
Publicado: (2021)

Polypharmacy and oral antidiabetic treatment for type 2 diabetes characterised by drug class and patient characteristics: A Japanese database analysis
por: Horii, Takeshi, et al.
Publicado: (2019)

The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
por: Feng, Yin-Hsun, et al.
Publicado: (2011)

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes
por: Tschöpe, Diethelm, et al.
Publicado: (2013)

Antidiabetic effects of Brucea javanica seeds in type 2 diabetic rats
por: Ablat, Abdulwali, et al.
Publicado: (2017)

Prescribing patterns of antidiabetics in type 2 diabetes and factors affecting them
por: Allyhiani, Moayad, et al.
Publicado: (2022)

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database
por: Tzoulaki, Ioanna, et al.
Publicado: (2009)

Treatment of Urinary Tract Infections with Canephron(®) in Germany: A Retrospective Database Analysis
por: Höller, Martina, et al.
Publicado: (2021)

Incidence of fractures in young women with breast cancer - a retrospective cohort study
por: Stumpf, Ulla, et al.
Publicado: (2019)

Prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia
por: Kostev, Karel, et al.
Publicado: (2017)

Risk of psychiatric and neurological diseases in patients with workplace mobbing experience in Germany: a retrospective database analysis
por: Kostev, Karel, et al.
Publicado: (2014)

Anti-diabetic treatment regulates pro-fibrotic TGF-β serum levels in type 2 diabetics
por: Pscherer, Stefan, et al.
Publicado: (2013)

Persistence of oral antidiabetic treatment for type 2 diabetes characterized by drug class, patient characteristics and severity of renal impairment: A Japanese database analysis
por: Kadowaki, Takashi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ild0pil4944c6qioqp15rnjuc1